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Abstract 1 
 2 
The most common phytosterols in the human diet are sitosterol and campesterol, 3 
which originate exclusively from plant derived food. These phytosterols are taken up 4 
by NPC1L1 transport from the intestine into the enterocytes together with cholesterol 5 
and other xenosterols. Phytosterols are selectively pumped back from the 6 
enterocytes into the intestinal lumen and on the liver site from hepatocytes into bile 7 
by heterodimeric ABCG5/G8 transporters. Like cholesterol, both phytosterols are 8 
prone to ring and side chain oxidation. It could be shown that oxyphytosterols, found 9 
in atherosclerotic tissue, are most likely of in situ oxidation (Schött et al.; Biochem 10 
Biophys Res Commun. 2014 Apr 11;446(3):805-10). However, up to now, the entire 11 
mechanism of phytosterol oxidation is not clearly understood. Here, we provide 12 
further information about the oxidation of sitosterol and the transport of its oxidation 13 
products out of tissue. Our survey includes data of 104 severe aortic stenosis 14 
patients that underwent an elective aortic valve cusp replacement. We studied their 15 
phytosterol concentrations, as well as absolute and substrate corrected 16 
oxyphytosterol levels in plasma and valve cusp tissue. In addition, we also examined 17 
phytosterol and oxyphytosterol concentrations in plasma and tissues (from brain and 18 
liver) of 10 male ApoE knockout mice. The ratio of 7-oxygenated-sitosterol-to-19 
sitosterol exceeds the ratio for 7-oxygenated-campesterol-to-campesterol in plasma 20 
and tissue of both humans and mice. This finding indicates that sitosterol is oxidized 21 
to a higher amount than campesterol and that a selective oxidative mechanism might 22 
exist which can differentiate between certain phytosterols. Secondly, the 23 
concentrations of oxyphytosterols found in plasma and tissue support the idea that 24 
oxysitosterols are preferably transported out of individual tissues. Selective oxidation 25 
of sitosterol and preferred transport of sitosterol oxidation products out of tissue seem 26 
to be a metabolic pathway of forced sitosterol clearance from tissue compartments. 27 
 28 
Key words: sitosterol, phytosterol, oxyphytosterol, oxidation, transport, metabolism 29 
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Introduction 1 
 2 
Phytosterols are neutral sterols which are structurally similar to cholesterol but 3 
exclusively synthesized by plants [1]. Like cholesterol in animals, phytosterols take 4 
over the role of integral membrane components in plants [2]. The most common 5 
phytosterols are sitosterol and campesterol that differ from cholesterol in the 6 
modification of the side chain [3, 4]. In sitosterol and campesterol a hydrogen atom at 7 
position C24 is substituted by an additional ethyl- or methyl-group. Phytosterols 8 
determined in animal tissue and body fluids can exclusively originate from absorbed 9 
plant diet, whereby sitosterol is the phytosterol that occurs in highest concentrations 10 
in the human and animal diet, followed by campesterol. However, conditions are 11 
different in blood and normally the concentration of campesterol exceeds the 12 
sitosterol concentration. The fractional absorption rate of campesterol in the intestine 13 
is threefold higher compared with sitosterol [5, 6]. Similar to cholesterol, phytosterols 14 
are prone to autoxidation by the presence of oxygen, heat, light and transition metals. 15 
Under these conditions phytosterols form autoxidative products such as 7α- or 7β-16 
diols, 5α, 6α-epoxids; 5β, 6β-epoxids; and cholestane-triols; as well as 7-keto-17 
oxyphytosterols [7-9]. Until the present day it is understood that oxyphytosterols can 18 
be formed by a radical mechanism at the ring structure or at the side chain and that 19 
some side chain oxyphytosterols might to be formed enzymatically [10, 11].  20 
 21 
The main pathway of cholesterol metabolism is the degradation to primary bile acids 22 
and excretion via the bile. Contrary to cholesterol, phytosterols cannot follow this 23 
excretion and detoxification pathway because of a different substitution at position 24 
C24 which prevents side chain shortening [12]. Only little information with regard to 25 
the phytosterol and oxyphytosterol metabolism is available and still basic questions 26 
have to be answered: 1) How are the absorbed and endogenously formed 27 
oxyphytosterols transported within or into the blood circulation? 2) How is the 28 
transport mechanism designed that transfers oxyphytosterols between extracellular 29 
and intracellular compartments? 3) What is the mechanism to form oxyphytosterols? 30 
4) Do oxyphytosterols play a role in the metabolism of phytosterols? Additionally, 31 
data on the origin of oxyphytosterols in the human circulation, their distribution in 32 
different body compartments, and their intestinal absorption rates from the diet are 33 
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rare. Among available models, the apolipoprotein E- deficient (apoE-/-) mouse is 1 
particularly popular because of its propensity to spontaneously develop 2 
atherosclerotic lesions on a standard chow diet. On western type diet the apoE-/- 3 
mouse demonstrates very high levels of circulating cholesterol and plant sterol levels. 4 
Development of atherosclerosis and oxidative processes in normal mice would take 5 
longer periods of treatment with western type diets [13]. Another option would have 6 
been to take LDL-R k.o. mice. Fortunately, data and material from oxyphytosterol 7 
ingestion studies in ApoE k.o. mice were available [14, 15]. The article on hand will 8 
give further descriptive insights in the oxidation of phytosterols and transport of its 9 
products in humans and ApoE-/- mice. As result of the evaluation in humans and 10 
mice, selective oxidation of sitosterol in peripheral tissue could be a protective 11 
measure to control local plant sitosterol concentrations. 12 
 13 
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Material and Methods 1 
 2 
This article summarizes the results of our survey on absolute phytosterol and 3 
oxyphytosterol (OPS) concentrations and the ratio of oxyphytosterol-to-substrate 4 
(OPS-to-substrate) concentrations of plasma and aortic valve tissue of human 5 
patients that underwent an aortic valve cusp replacement due to severe aortic 6 
stenosis. Selective phytosterol oxidation and transport of its oxidation products from 7 
the aortic valve cusps tissue into the circulation are investigated. Correlations of 8 
phytosterols and oxyphytosterols in plasma and tissue and between plasma and 9 
tissue, as well as the relationship of phytosterols and oxyphytosterols in patients with 10 
coronary artery diseases (CAD) found in the very same data set have already been 11 
recently published [16, 17]. In a follow-up survey, the assumptions encountered on 12 
the basis of the human data were also tested in an ApoE -/- knockout mouse model.  13 
 14 
Human study 15 
In this study 104 patients (36 females/68 males) between 40 to 87 years of age (BMI 16 
28.4 ± 6.2 kg/m2) were included. They were admitted to the hospital for elective aortic 17 
valve replacement due to severe aortic stenosis. At admission, a detailed medical 18 
history was taken with special attention to established cardiovascular risk factors and 19 
statin treatment. Table 1A and 1B refer to the individual absolute plant sterol and 20 
oxyphytosterol levels in human serum and human aortic valve cusp tissues 21 
comparing gender specific differences and patients with or without diabetes type 2 22 
(Fig. 1A), statin versus non-statin users, as well as smokers and non-smokers (Fig. 23 
1B). 24 
Venous blood samples were obtained the day before the scheduled aortic valve 25 
replacement. Blood samples were centrifuged immediately after blood drawing for 5 26 
min at 4000 rpm. Per milliliter plasma 0.25 mg butylated hydroxytoluene (BHT) was 27 
added as an antioxidant to avoid autoxidation during sample storage. The plasma 28 
samples were stored at -20 °C until analysis. Aortic cusps were removed from aortic 29 
rings during the operation and kept frozen at -80 °C until sample work-up. Excised 30 
valve cusps were dried in a Savant™ SpeedVac™ concentrator (Thermo Fisher 31 
Scientific, Schwerte, Germany) for 24 h and the calcified parts mechanically sorted 32 
from the valve cusps tissue as described in detail by our group [17]. The study 33 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
6 
 
protocol was approved by the institutional and governmental guidelines of the 1 
University Hospital of Saarland, Homburg, Germany. 2 
 3 
Animal study 4 
Male apoE-/-(C57/Bl6 genetic background) mice, 8-12 weeks of age, weighing 20-25 5 
g were purchased from Charles River, Sulzfeld, Germany. The 10 apoE-/- mice were 6 
fed a “Western-type” diet (40 kcal% butterfat, 0.15% (w/w) cholesterol, 0.054 +/- 7 
0.006 µg/mg campesterol and 0.084 +/- 0.009 µg/mg sitosterol.). Diets were 8 
prepared by the SNIFF Company (Soest, Germany). Over the 4 week study period 9 
mice had ad libitum access to water and chow. Each day of the study period the mice 10 
were intraperitoneally injected with 250 µL of 30% cyclodextrin dissolved in 0.9% 11 
sodium chloride solution. After 4 weeks the animals were sacrificed by intravenous 12 
injection of a mixture of ketamin (1 g/kg body weight)/xylazin (0.1 g/kg body weight). 13 
Venous blood samples were drawn from the abdominal vena cava with EDTA blood 14 
plasma monovettes (Sarstedt, Nümbrecht, Germany). Plasma was separated by 15 
centrifugation at 3500 rpm for 10 min at 18 °C (Heraues multifuge 4KR centrifuge, 16 
Osterode, Germany). To avoid autoxidation 250 µg butylated hydroxytoluene (solved 17 
in methanol) were added to 1 mL plasma. Livers, brains and descending aorta were 18 
excised and washed in an ice-cold phosphate buffer solution. Plasma and organs 19 
were stored at -70 °C. Aliquots of the organs were dried in a Savant™ SpeedVac™ 20 
concentrator (Thermo Fisher Scientific, Schwerte, Germany) for 12 h at 4 °C. Animal 21 
experiments were performed in accordance with the German animal protection law 22 
 23 
Phytosterol and oxyphytosterol extraction and GC-MS determination 24 
The phytosterols campesterol and sitosterol and the oxyphytosterols (7α-OH-, 7β-25 
OH- and 7keto-campesterol/sitosterol) were extracted from tissue aliquots (dry 26 
weight) with 10 mL Folch-reagent (chloroform/methanol; 3:1; v:v) per mg tissue. 27 
Butylated hydroxytoluene (BHT) (0.25 mg added per mL solvent) was used as 28 
antioxidant and added prior to extraction [14, 16, 17]. Extraction was performed for 29 
48 h at 4 °C in a dark cold room. The extracts were kept at -20 °C until analysis. One 30 
mL plasma and two mL of the Folch extract of valve cusps were used for sterol and 31 
oxyphytosterol determination in the human experiment. Fifty microliters of mouse 32 
plasma and two mL of the Folch extract of liver and brain tissue was used for sterol 33 
and oxyphytosterol determination in the human experiment. After alkaline hydrolysis 34 
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phytosterols were extracted by cyclohexane and OPS using dichloromethane in two 1 
different work-up processes. Phytosterols and oxyphytosterols in both, the human 2 
and animal study, were derivatized to the corresponding trimethylsilyl- (TMSi-) ethers 3 
and determined by gas chromatography - mass selective detection (using 4 
epicoprostanol for phytosterols and using the corresponding deuterium labeled 5 
oxyphytosterols as internal standards for oxyphytosterols) as described in detail 6 
previously [18, 19].  7 
 8 
Statistical analyses 9 
Data were tested for normal and Gaussian distribution. Differences for phytosterols 10 
and oxyphytosterols between gender, statin and non-statin users, patients with and 11 
without diabetes mellitus type 2, as well as smokers and non-smokers were tested by 12 
unpaired, two-tailed Student´s t-test. Differences of the mean of phytosterols, 13 
oxyphytosterols and the ratio of oxyphytosterol-to-substrate in plasma and tissue of 14 
the human population and ApoE knockout mice were tested by unpaired, two-tailed 15 
Student´s t-test. The data are reported as mean ± SD. All statistical tests were 16 
performed with SPSS 21 (Chicago, Illinois, U.S.A.) software. 17 
  18 
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Results 1 
In the whole patient population there was no influence of gender, diabetes mellitus, 2 
smoking habits, and statin treatment on phytosterol and oxyphytosterol 3 
concentrations in the plasma and tissue observed (see baseline characteristics of the 4 
patient population listed in Table 1A and 1B).  5 
 6 
Preferential oxidation of sitosterol in the circulation of humans and ApoE knockout 7 
mice 8 
The average sitosterol concentrations in human plasma and aortic valve tissue were 9 
determined with 68.8% and 77.8% of the concentrations of campesterol. Contrary to 10 
the findings for phytosterols, the ratios of the total oxidized-sitosterol-to-sitosterol 11 
compared to the ratio of total oxidized-campesterol-to-campesterol were 3.27-fold 12 
and 1.42-fold higher in plasma and tissue in humans (see also Table 2 and Table 3). 13 
Based on previous findings in this patient collective oxyphytosterols appear to be 14 
formed in situ [17].  As less sitosterol will reach the tissue we would expect lower 15 
oxysitosterol serum and tissue levels if there is no differentiation between the 16 
oxidation rates of campesterol to sitosterol. However, serum and tissue levels of 17 
absolute oxysitosterol levels were 2.4 and 1.12-fold higher than the oxycampesterol 18 
levels (p<0.001 for both). This indicates a preferred oxidation for sitosterol. Corrected 19 
levels of oxysitosterol appear even more significantly higher. Oxyphytosterol 20 
concentrations correct for the substrate are used as a marker for the degree of 21 
oxidation in dependency of the present substrate level. 22 
 23 
To test this assumption based on findings in the human population and to achieve 24 
information about other tissues, we evaluated phytosterol and oxyphytosterol 25 
concentrations in plasma, brain and liver tissue of ApoE knockout mice (Table 2 and 26 
3) Like in the human study, sitosterol concentrations in plasma, liver and brain are 27 
lower than campesterol concentrations in ApoE knockout mice. The ratio of total 7-28 
oxygenated-sitosterol-to-sitosterol, compared to the ratio of total 7-oxygenated-29 
campesterol-to-campesterol were 4.10-, 2.03-, 3.70-fold higher in plasma, liver and 30 
brain, respectively. In addition, the animal data also support the assumption that in 31 
particular sitosterol is more suspended to oxidative processes than campesterol in 32 
humans and ApoE (-/-) mice. 33 
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Preferential transport of sitosterol oxidation products from tissue into the circulation 1 
Absolute oxyphytosterol concentrations and the ratio of oxyphytosterol-to-substrate 2 
were determined in plasma and tissue samples from the human patient collective 3 
(Table 2 and Table 3). In aortic valve cusps tissue, the absolute 7α-OH-, and 7β-OH-4 
campesterol concentrations and their ratio OPS-to-substrate are significantly higher 5 
compared to the concentrations of the corresponding sitosterol oxidation products. 6 
Contrary to the human aortic valve cusps tissue, the absolute concentrations and the 7 
ratios of OPS-to-substrate of 7β-OH-sitosterol in plasma are significantly higher than 8 
that of 7β-OH-campesterol. 9 
However, considering the mainly local origin of 7β-OH-sitosterol in the valve cusps 10 
tissue, our results could still indicate that a preferable transport of 7β-OH-sitosterol 11 
from the aortic valve cusp tissue into the blood circulation could exist; and that this 12 
causes the variations of both 7β-oxyphytosterol concentrations between plasma and 13 
tissue. In addition, the individual ratios of 7α-OH-, 7β-OH-, 7keto-sitosterol to their 14 
corresponding campesterol oxidation products in human plasma are significantly 15 
higher than those found in aortic valve cusp tissue (Table 3). 16 
 17 
To validate these results found in the human patient collective, absolute phytosterol 18 
concentrations and the ratios phytosterol-to-substrate in plasma, liver and brain of 10 19 
ApoE knockout mice were examined (see Table 2 and Table 3). In ApoE knockout 20 
mice, we found absolute brain and liver tissue concentrations of 7α-OH- and 7β-OH-21 
campesterol significantly higher than those of the corresponding 7-oxygenated-22 
sitosterols. In brain tissue, we found that 7keto-sitosterol is 1.39-fold increased. 23 
Considering the relatively high standard deviation of the 7keto-phytosterols in the 24 
brain and the fact that the sum of oxy-campesterol are not significantly different from 25 
the oxy-sitosterol levels these data in total should not be overinterpretated.  26 
 27 
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Discussion 1 
 2 
In plasma and tissue of both, humans and ApoE (-/-) mice, we found the same 3 
pattern of the different 7-oxygenated phytosterols. Our results give evidence that on 4 
one hand, sitosterol is selectively oxidized and on the other hand, its oxidation 5 
products (especially 7β-OH-sitosterol) are preferably transported from tissue into the 6 
circulation in human and mice. Summarized, our findings allow the hypothesis that 7 
selective oxidation of sitosterol and preferred transport of its oxidation products from 8 
peripheral tissue could be considered as pathway mechanism to reduce sitosterol 9 
concentrations in peripheral body tissues. 10 
 11 
The transport and metabolism of phytosterols within the human body is not yet 12 
completely understood. A selective mechanism that is preferentially oxidizing 13 
individual phytosterols at position C7 is not described until the present day. The 14 
results of our human and animal studies show, despite the fact of significant lower 15 
sitosterol concentrations in plasma and tissues, that absolute oxysitosterol 16 
concentrations and the sum of the ratio of oxysitosterols-to-sitosterol are higher than 17 
the corresponding values of campesterol, its oxidation products, and the ratios of the 18 
oxygenated campesterol to campesterol. This finding allows the conclusion that any 19 
kind of selective or preferred oxidation especially of sitosterol might exist. However, 20 
our data give no insight in which way this oxidation process could be designed. 21 
Several mechanisms that can cause a selective oxidation of individual phytosterols 22 
can be discussed: 1) By now it has not been documented if oxygenases, which 23 
metabolize cholesterol, reveal additional activity for phytosterols. 2) Additionally, it 24 
has not been tested yet if other known enzymes, involved in metabolic processes, 25 
dispose distinct activity for a ring oxidation of sitosterol. However, regarding the 26 
concentration pattern of 7α-OH-, 7β-OH- and 7keto-phytosterols, which is similar to 27 
the cholesterol autoxidation pattern, we have to assume that most of the 28 
oxyphytosterols in the human circulation originate from an endogenic oxidation 29 
process triggered by radicals [20]. This circumstance would strengthen the idea of a 30 
non-enzymatic oxidation process. 3) Therefore, a non-enzymatic oxidation process 31 
could be discussed. It is generally assumed that phytosterols, like other Δ5-32 
unsaturated sterols are prone to autoxidation by reactive oxygen species (ROS) at 33 
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the allylic C7 position [9, 21-23]. Additionally, it is assumed that oxidation by ROS, e. 1 
g. superoxide or hydroperoxide, is neither a structure selective nor a stereo- selective 2 
process, because ROS lacking any structure that could determine region specificity. 3 
Phytosterols from cell plasma membrane areas and internal cell membranes areas 4 
could be transported to cell compartments with oxidative activity within one of the 5 
organelles of the cytoplasm. However, the cell compartments in which oxidation of 6 
phytosterols occur are not know yet and must be identified. In these compartments, 7 
possibly microsomes or peroxisomes, phytosterols could undergo oxidative 8 
processes. Proteins that selectively enrich sitosterol in cell compartments could exist 9 
and lead to locally higher concentrations of sitosterol within this specific cell 10 
compartments. In these compartments a non-enzymatic oxidation of all sterols could 11 
take place which would result in higher oxidation rates for sitosterol than for 12 
campesterol. Reproducible determinations of sterol and oxysterol concentrations in 13 
different cell compartments are very difficult. To our knowledge, no comprehensive 14 
studies have been performed so far to study the subcellular distribution of 15 
phytosterols and oxyphytosterols. Therefore, a selective enrichment of individual 16 
phytosterols in different cell compartments and the design of this enrichment 17 
mechanism must be demonstrated to support this assumption. 4) Finally, beside 18 
other possible oxidation mechanism, it is conceivable that phytosterols absorbed 19 
from lipoproteins are directly oxidized after uptake by the cell. However, only more 20 
careful research on oxidation processes of phytosterols will give clear insight on the 21 
selective sitosterol oxidation process.  22 
 23 
Previously, our group could demonstrate that the oxyphytosterols in the aortic valve 24 
originate from local oxidation processes in the tissue [17]. In the human study the 25 
average aortic valve cusp tissue concentrations of 7β-OH-sitosterol are lower than 26 
concentrations of 7β-OH-campesterol (0.019 ± 0.010 ng/mg vs. 0.048 ± 0.030 27 
ng/mg). The animal study supports our finding with higher 7β-OH-campesterol 28 
concentrations compared to 7β-OH-sitosterol concentrations in brain (0.14 ± 0.07 29 
ng/mg vs. 0.06 ± 0.01 ng/mg) and liver tissue (0.91 ± 0.79 ng/mg vs. 0.44 ± 0.22 30 
ng/mg), respectively. Considering that 7β-OH-sitosterol concentrations in human and 31 
mouse plasma are higher than 7β-OH-campesterol concentrations, these differences 32 
suggest that in this tissues explicit transport mechanisms exist that force an efflux of 33 
7β-OH-sitosterol out of the cell. We were able to show that 7β-OH-sitosterol 34 
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generates significant oxidative stress in the arterial wall of ApoE (-/-) mice which 1 
could reason a selective transport out of the cell as protective mechanism [15].  2 
 3 
Despite the fact, that the human diet contains between about 150-450 mg/day 4 
phytosterols the physiological phytosterol concentrations are a hundred times lower 5 
than that of cholesterol in the human circulation [24]. This circumstance is caused by 6 
the low (only 0.5-2.0%) absolute absorption rate of phytosterols from the diet [25]. In 7 
addition, Lütjohann et al. showed that the fractional absorption of oxidized 8 
campesterols is three times higher than that of oxidized sitosterols [5, 6].  9 
Several physiological mechanisms involved in sterol absorption are identified which 10 
collectively collaborate to regulate phytosterol, in particular sitosterol, concentrations 11 
in low concentrations ranges in the human circulation: 1) It could been shown that the 12 
sterol uptake transporter Niemann-Pick 1 like 1 reveals lower affinity to sitosterol than 13 
to cholesterol; 2) the ATP binding cassette transporter ABCG5/G8 at the intestine 14 
pumps back absorbed phytosterols into the intestinal lumen [26, 27]. In the liver the 15 
same transporter facilitates the transport of sterols into the bile [26, 27]. Generally, 16 
this ABCG5/G8 transporter reveals higher affinity to sitosterol than to campesterol 17 
which leads to a higher excretion of sitosterol; 3) Sitosterol is only a poor substrate 18 
for acyl-CoA:cholesterol acyltransferase 1 which results in lower esterification rates 19 
than that of cholesterol [26, 27]. However, despite these effective mechanisms which 20 
control phytosterol concentrations in the human circulation, the remaining amounts of 21 
the absorbed sitosterol and campesterol are transported within the blood stream to 22 
different organs and will be distributed in all kind of different tissues of the organism. 23 
Up to now, only little information about the phytosterol storage in peripheral tissue 24 
compartments and the return transport of phytosterols for its elimination is known. 25 
Oxidation of cholesterol and transport in form of oxy(chole)sterols is a fundamental 26 
mechanism for cholesterol homeostasis in the brain and of the reverse cholesterol 27 
transport from peripheral tissue [28-31].  28 
Our findings allow the hypothesis that oxidation of sitosterol and especially its 29 
transport from peripheral tissues into the blood stream and eventually to the liver 30 
could represent a metabolic mechanism that allow the reduction of tissue sitosterol 31 
concentrations and return transport for excretion in form of oxysitosterols. Our survey 32 
strongly supports this hypothesis by showing selective oxidation of sitosterol and 33 
selective transport of its oxidation products from different tissues in ApoE (-/-) mice 34 
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and humans. For the first time we can give information about a putative excretion and 1 
transport mechanism which, additionally to the already described phytosterol 2 
absorption rate lowering mechanism, allows the control of phytosterol concentrations 3 
in peripheral tissue.. In conclusion, only more carefully performed experiments on 4 
transport, oxidation and intracellular distribution of phytosterols and oxyphytosterols 5 
can support our results and confirm the hypothesis of oxidative phytosterol 6 
metabolism in peripheral tissue. 7 
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Table 1 A. Absolute and cholesterol corrected plant sterol and absolute oxyphytosterol levels in human serum, 
stratified for differences by gender and in patients with diabetes mellitus type 2
p- value
a)
p- value
a)
campesterol [mg/dL] 0.378 ± 0.206 0.360 ± 0.230 0.692 0.373 ± 0.242 0.348 ± 0.158 0.630
sitosterol [mg/dL] 0.270 ± 0.145 0.243 ± 0.153 0.379 0.259 ± 0.166 0.230 ± 0.094 0.386
7α-OH-campesterol [ng/mL] 0.146 ± 0.259 0.137 ± 0.129 0.806 0.134 ± 0.125 0.157 ± 0.301 0.596
7α-OH-sitosterol [ng/mL] 0.062 ± 0.025 0.068 ± 0.052 0.524 0.067 ± 0.050 0.065 ± 0.026 0.907
7β-OH-campesterol [ng/mL] 0.204 ± 0.075 0.229 ± 0.106 0.164 0.226 ± 0.100 0.207 ± 0.088 0.389
7β-OH-sitosterol [ng/mL] 0.507 ± 0.152 0.518 ± 0.209 0.768 0.517 ± 0.206 0.508 ± 0.142 0.846
7keto-campesterol [ng/mL] 0.885 ± 0.315 0.939 ± 0.352 0.438 0.943 ± 0.378 0.872 ± 0.190 0.360
7keto-sitosterol [ng/mL] 2.552 ± 0.963 2.451 ± 0.810 0.575 2.518 ± 0.922 2.417 ± 0.686 0.609
∑ oxy-campesterol [ng/mL] 1.235 ± 0.430 1.305 ± 0.513 0.485 1.303 ± 0.524 1.236 ± 0.368 0.544
∑ oxy-sitosterol [ng/mL] 3.121 ± 1.097 3.037 ± 1.021 0.702 3.101 ± 1.119 2.990 ± 0.815 0.644
∑ oxyphytosterols [ng/mL] 4.355 ± 1.390 4.343 ± 1.467 0.966 4.405 ± 1.568 4.226 ± 0.995 0.588
campesterol [ng/mg] 57.61 ± 42.87 53.41 ± 34.98 0.591 52.15 ± 35.52 64.72 ± 43.57 0.145
sitosterol [ng/mg] 45.95 ± 32.74 40.79 ± 25.88 0.381 40.76 ± 26.37 49.29 ± 33.80 0.189
7α-OH-campesterol [ng/mg] 0.052 ± 0.031 0.061 ± 0.036 0.203 0.058 ± 0.036 0.061 ± 0.032 0.701
7α-OH-sitosterol [ng/mg] 0.011 ± 0.005 0.012 ± 0.006 0.535 0.011 ± 0.006 0.012 ± 0.005 0.814
7β-OH-campesterol [ng/mg] 0.043 ± 0.028 0.050 ± 0.031 0.254 0.048 ± 0.031 0.050 ± 0.028 0.762
7β-OH-sitosterol [ng/mg] 0.018 ± 0.009 0.019 ± 0.010 0.503 0.018 ± 0.010 0.020 ± 0.009 0.414
7keto-campesterol [ng/mg] 0.275 ± 0.116 0.268 ± 0.088 0.749 0.266 ± 0.084 0.289 ± 0.131 0.306
7keto-sitosterol [ng/mg] 0.396 ± 0.155 0.390 ± 0.108 0.812 0.387 ± 0.104 0.415 ± 0.176 0.341
∑ oxy-campesterol [ng/mg] 0.370 ± 0.156 0.380 ± 0.138 0.745 0.372 ± 0.134 0.400 ± 0.170 0.392
∑ oxy-sitosterol [ng/mg] 0.425 ± 0.165 0.421 ± 0.117 0.883 0.417 ± 0.112 0.446 ± 0.186 0.338
∑ oxyphytosterols [ng/mg] 0.795 ± 0.313 0.800 ± 0.230 0.917 0.789 ± 0.221 0.846 ± 0.349 0.331
a)Student´s t-test unpaired
gender diabetes mellitus type 2
human aortic valve cusp tissue
human serum
female 
(n = 36)
male
(n =n 68)
no typ 2 DM
(n = 76)
typ 2 DM
(n = 26)
Table
Table 1 B. Absolute and cholesterol corrected plant sterol and absolute oxyphytosterol levels in human serum, 
stratified for statin-users versus non-users and smoker versus non-smoker
p- value
a)
p- value
a)
campesterol [mg/dL] 0.396 ± 0.275 0.350 ± 0.188 0.374 0.352 ± 0.219 0.382 ± 0.225 0.494
sitosterol [mg/dL] 0.295 ± 0.207 0.229 ± 0.103 0.081 0.246 ± 0.141 0.259 ± 0.161 0.668
7α-OH-campesterol [ng/mL] 0.185 ± 0.277 0.118 ± 0.104 0.175 0.112 ± 0.086 0.175 ± 0.253 0.109
7α-OH-sitosterol [ng/mL] 0.070 ± 0.048 0.064 ± 0.043 0.482 0.062 ± 0.031 0.070 ± 0.056 0.339
7β-OH-campesterol [ng/mL] 0.239 ± 0.098 0.210 ± 0.095 0.155 0.189 ± 0.075 0.257 ± 0.107 0.000
7β-OH-sitosterol [ng/mL] 0.525 ± 0.149 0.509 ± 0.209 0.681 0.483 ± 0.155 0.552 ± 0.221 0.064
7keto-campesterol [ng/mL] 0.976 ± 0.394 0.892 ± 0.305 0.234 0.862 ± 0.286 0.989 ± 0.385 0.058
7keto-sitosterol [ng/mL] 2.632 ± 0.947 2.411 ± 0.814 0.220 2.368 ± 0.775 2.627 ± 0.947 0.130
∑ oxy-campesterol [ng/mL] 1.399 ± 0.584 1.220 ± 0.417 0.111 1.163 ± 0.349 1.421 ± 0.582 0.010
∑ oxy-sitosterol [ng/mL] 3.228 ± 1.100 2.984 ± 1.012 0.263 2.913 ± 0.914 3.250 ± 1.163 0.103
∑ oxyphytosterols [ng/mL] 4.627 ± 1.527 4.203 ± 1.372 0.156 4.076 ± 1.212 4.670 ± 1.614 0.035
campesterol [ng/mg] 54.43 ± 35.72 55.09 ± 39.03 0.932 54.36 ± 39.16 55.44 ± 36.42 0.885
sitosterol [ng/mg] 45.37 ± 26.78 41.09 ± 29.29 0.467 41.32 ± 28.37 44.03 ± 28.64 0.630
7α-OH-campesterol [ng/mg] 0.052 ± 0.036 0.061 ± 0.034 0.198 0.053 ± 0.032 0.064 ± 0.038 0.115
7α-OH-sitosterol [ng/mg] 0.011 ± 0.005 0.012 ± 0.006 0.813 0.011 ± 0.004 0.012 ± 0.007 0.253
7β-OH-campesterol [ng/mg] 0.042 ± 0.029 0.051 ± 0.031 0.187 0.044 ± 0.027 0.052 ± 0.033 0.151
7β-OH-sitosterol [ng/mg] 0.017 ± 0.009 0.019 ± 0.010 0.338 0.018 ± 0.008 0.019 ± 0.011 0.347
7keto-campesterol [ng/mg] 0.280 ± 0.096 0.265 ± 0.099 0.461 0.261 ± 0.106 0.282 ± 0.088 0.286
7keto-sitosterol [ng/mg] 0.401 ± 0.082 0.388 ± 0.144 0.620 0.380 ± 0.134 0.406 ± 0.115 0.297
∑ oxy-campesterol [ng/mg] 0.375 ± 0.156 0.377 ± 0.138 0.934 0.358 ± 0.147 0.398 ± 0.138 0.158
∑ oxy-sitosterol [ng/mg] 0.429 ± 0.094 0.418 ± 0.153 0.703 0.409 ± 0.142 0.438 ± 0.126 0.274
∑ oxyphytosterols [ng/mg] 0.804 ± 0.241 0.796 ± 0.272 0.879 0.767 ± 0.280 0.836 ± 0.233 0.178
a) Student´s t-test, unpaired
human serum
human aortic valve cusp tissue
statin treatment smoking
no statin 
(n = 36)
statin
(n = 68) 
non smoker 
(n = 56)
smoker 
(n = 48)
Table
Table 2) Absolute phytosterol and oxyphytosterol concentrations in plasma and tissue of humans (n=104) and ApoE knockout mice (n=10). 
ratio
a)
p- value
c)
ratio
b)
p- value
c)
ratio
b)
p- value
c)
ratio
b)
p- value
c)
ratio
b)
p- value
c)
human plasma 0.37 ± 0.22 0.25 ± 0.15 0.68 < 0.001 0.14 ± 0.18 0.07 ± 0.04 0.46 < 0.001 0.22 ± 0.10 0.51 ± 0.19 2.32 < 0.001 0.92 ± 0.34 2.49 ± 0.86 2.71 < 0.001 1.28 ± 0.48 3.07 ± 1.04 2.40 < 0.001
ApoE (-/-) mice plasma 11.31 ± 2.71 3.39 ± 0.96 0.30 < 0.001 84.71 ± 49.39 47.72 ± 21.48 0.56 0.005 273.7 ± 158.1 405.1 ± 151.8 1.48 0.010 264.9 ± 137.0 294.8 ± 206.9 1.11 0.392 614.9 ± 284.6 742.8 ± 322.1 1.21 0.133
human aortic valve tissue 54.86 ± 37.74 42.57 ± 28.39 0.78 < 0.001 0.06 ± 0.03 0.01 ± 0.01 0.20 < 0.001 0.05 ± 0.03 0.02 ± 0.01 0.39 < 0.001 0.27 ± 0.10 0.39 ± 0.13 1.45 < 0.001 0.38 ± 0.14 0.42 ± 0.14 1.12 < 0.001
ApoE (-/-) mice liver 0.21 ± 0.05 0.07 ± 0.02 0.33 < 0.001 0.77 ± 0.76 0.09 ± 0.06 0.11 0.013 0.91 ± 0.79 0.44 ± 0.22 0.48 0.036 1.88 ± 1.10 1.76 ± 0.70 0.94 0.445 3.56 ± 2.61 2.29 ± 0.91 0.64 0.047
ApoE (-/-) mice brain 0.07 ± 0.01 0.02 ± 0.00 0.33 < 0.001 0.13 ± 0.08 0.02 ± 0.01 0.16 0.003 0.14 ± 0.07 0.06 ± 0.01 0.44 0.009 1.08 ± 0.22 1.50 ± 0.69 1.39 0.027 1.33 ± 0.28 1.58 ± 0.70 1.18 0.211
a) 
ratio of sitosterol to campesterol
b) ratio of 7-oxidized sitosterol to corresponding 7-oxidized campesterol
c)
 P -values calculated with Student´s t-test, two tailed, unpaired
7β-OH-
sitosterol
campesterol sitosterol 7α-OH-
campesterol
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sitosterol
7β-OH-
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7keto-
campesterol
7keto-
sitosterol
Σ oxy-
campesterol
Σ oxy-
sitosterol
[ng/mL] [ng/mL] [ng/mL][ng/mL] [ng/mL][mg/dL] [mg/dL] [ng/mL] [ng/mL] [ng/mL]
[ng/mg] [ng/mg][ng/mg] [ng/mg] [ng/mg] [ng/mg] [ng/mg][ng/mg] [ng/mg] [ng/mg]
Table
ratio
a)
p-value
b)
ratio
a)
p-value
b)
p-value
b) p-value ratio
a)
p-value
b)
human plasma 0.04 ± 0.05 0.03 ± 0.02 0.69 0.001 0.07 ± 0.04 0.24 ± 0.11 3.26 <0.001 0.32 ± 0.19 1.16 ± 0.52 3.63 <0.001 0.44 ± 0.24 1.43 ± 0.62 3.27 < 0.001
ApoE (-/-) mice plasma 0.78 ± 0.45 1.58 ± 0.96 2.02 0.002 2.46 ± 1.48 12.65 ± 5.92 5.15 < 0.001 2.33 ± 1.17 8.43 ± 5.41 3.62 0.002 5.49 ± 2.56 22.51 ± 9.50 4.10 < 0.001
human aortic valve tissue 1.27 ± 0.74 0.33 ± 0.17 0.26 < 0.001 1.01 ± 0.55 0.50 ± 0.23 0.49 < 0.001 6.99 ± 4.50 12.35 ± 6.73 1.77 <0.001 9.26 ± 5.13 13.18 ± 6.93 1.42 < 0.001
ApoE (-/-) mice liver 3.39 ± 3.08 1.18 ± 0.65 0.35 0.019 4.06 ± 2.74 6.33 ± 2.06 1.56 0.008 8.89 ± 4.51 25.64 ± 8.77 2.88 < 0.001 16.34 ± 10.00 33.15 ± 10.13 2.03 < 0.001
ApoE (-/-) mice brain 1.96 ± 1.19 1.02 ± 0.45 0.52 0.046 2.18 ± 1.10 2.93 ± 0.92 1.35 0.195 16.83 ± 4.50 73.00 ± 47.58 4.34 0.003 20.77 ± 5.34 76.84 ± 48.65 3.70 0.004
a) ratio of 7-oxidized sitosterol-to-substrate to corresponding 7-oxidized campesterol-to-substrate
b) p-values calculated with Student´s T-test, two tailed, paired
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campesterol
r_7α-OH-
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r_7β-OH-
campesterol
Table 3) Ratio of 7-oxygenated phytosterol concentrations to the corresponding substrate concentration in plasma and tissue of humans (n=104) and ApoE  knockout mice (n=10). 
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Table
